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Abstract
Hypertension is a major health issue, particularly in medically underserved populations that may suffer from poor
health literacy, poverty, and limited access to healthcare resources. Management of the disease reduces the risk of
adverse outcomes, such as cardiovascular or cerebrovascular events, vision impairment due to retinal damage, and
renal failure. In addition to pharmacological therapy, lifestyle modifications such as diet and exercise are effective in
managing hypertension. Current diet guidelines include the DASH diet, a low-fat and low-sodium diet that
encourages high consumption of fruits and vegetables. While the diet is effective in controlling hypertension,
adherence to the diet is poor and there are few applicable dietary alternatives, which is an issue that can arise from
poor health literacy in at-risk populations. The purpose of this review is to outline the effect of specific dietary
components, both positive and negative, when formulating a dietary approach to hypertension management that
ultimately aims to improve patient adherence to the treatment, and achieve better control of hypertension.
Keywords: Hypertension; Diet; Modulation; Blood pressure; Serum
potassium; Capsicum genus
Introduction
Hypertension is estimated by the Centers for Disease Control and
Prevention to affect approximately 30% of adults in the United States
[1]. It is a significant factor in the pathogenesis of a number of diseases,
including obesity, cardiovascular disease, and stroke [2-4].
Hypertension itself can be caused by unhealthy lifestyle habits like
alcoholism, drug addiction, smoking, high stress, or obesity, and
certain non-modifiable attributes like age, gender, hereditary and
genetic constitution, and racial or ethnic disparities.
Hypertension to an extent correlates to the prevailing
socioeconomic and geographical characteristics of a region, as well as
to individual behavioral factors, and can pose a significant public
health concern in populations defined by economic hardship, poverty,
reduced health care access, low health literacy, and lack of resources
due to geographic isolation [5-7]. For example, in the United States,
the prevalence of obesity is greatest in Appalachia, with West Virginia
leading the national rankings with 35.1% of adults with obesity and
41% with hypertension [8].
Treatment of hypertension centers on managing blood pressure
within a target range while trying to minimize drug-associated side
effects. Treatment protocol for hypertension is evolving, with
guidelines set forth by the JNC 7 in 2004, and again modified in the
JNC 8 in 2014. The JNC 7 defined blood pressure control as <140/90
mmHg, or <130/80 mmHg in those with kidney disease or diabetes,
whereas the JNC 8 suggested new standards in patients ≥ 60 years of
age without kidney disease or diabetes to <150/90 mmHg [9].
However, the recent SPRINT trial has taken a more aggressive
approach to blood pressure control, defining standard control as
systolic blood pressure (SBP) <140 mmHg, intensive control as SBP
<120 mmHg, and primary composite outcome as a cardiovascular or
cerebrovascular event, heart failure, or death. This trial demonstrated
for intensive treatment a hazard ratio of 0.75 with a 95% confidence
interval (CI) of 0.64 to 0.89 (p<0.001) for primary composite
outcomes, and an all-cause mortality hazard ratio of 0.73 (95% CI: 0.6
to 0.9, p=0.003). However, intensive therapy was associated with an
increased risk of adverse side effects, such as hypotension, syncope,
and electrolyte disturbances [10]. To achieve blood pressure control, a
wide array of pharmacological interventions is employed. Treatment
with antihypertensive drugs can reduce the risk of stroke by over 40%
and the risk of heart failure by approximately 50% [11,12].
Among the lifestyle and diet modifications that are recommended,
one that is recommended to all persons with hypertension, regardless
of pharmacological intervention, is the DASH (Dietary Approaches to
Stop Hypertension) diet, a diet that advocates the consumption of fiber
and potassium via fruits and vegetables, reduction in total and
saturated fat via a reduction in meat and animal products, and intake
of adequate protein via lean meat and low-fat dairy products instead of
high fat or processed meat [13]. This diet has been demonstrated to be
effective in managing blood pressure, with the original DASH feeding
trial demonstrating a decrease in SBP of 11.4 mmHg and a decrease in
diastolic blood pressure (DBP) of 5.5 mmHg compared to control
subjects [14]. However, a meta-analysis by Kwan et al. has
demonstrated significant challenges in maintaining adherence to the
protocol [14]. These findings are echoed in a study by Lin et al. that
showed that only 52% of obese adults in 2007 were advised by their
physician on healthy eating, and those who received no counseling
were less likely to adopt healthy eating practices (33% of uncounseled
versus 78% of counseled patients). Counseling by physicians and
lifestyle coaching by other professionals improved adherence to the
DASH diet, indicating the important role that the physician and
ancillary staff plays in promoting dietary changes as a component of
hypertension therapy [15].
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Certain diets rich in fruits and vegetables, such as the vegetarian
diet and the Mediterranean Diet, have demonstrated efficacy in
controlling blood pressure [16]. The mechanisms by which fruits and
vegetables are able to help manage blood pressure vary according to
their potassium content, flavonoid and polyphenol content, and fiber
content. Serum potassium levels have been shown to be inversely
associated with blood pressure, with antihypertensive dietary
interventions encouraging decreases in sodium consumption and
increases in potassium consumption in order to improve the sodium-
potassium ratio in the diet [17-19].
Pomegranate juice is rich in phytochemicals and polyphenols,
which have antioxidant and anti-inflammatory functions that have
been reported to promote cardiovascular health [20,21]. Pomegranate
juice may be able to prevent the development of high blood pressure
due to angiotensin II in diabetes via inhibition of angiotensin
converting enzyme (ACE) [22]. Experimental data as well as clinical
trials have shown that consumption of pomegranate juice has
antihypertensive effects [20, 21,23]. In a study of 13 hypertensive men
aged 39-68, 150 mL/day of natural pomegranate juice resulted in a
significant reduction of SBP (7%, from 125.38 ± 11.80 to 116.15 ± 7.94,
p=0.013) and DBP (6%, from 82.69 ± 5.25 to 78.08 ± 3.25, P <0.010)
[21]. In a study by Mohan et al. daily administration of 100 mg/kg and
300 mg/kg of pomegranate juice extract in diabetic Wistar rats for 4
weeks was found to reduce the main arterial blood pressure and
vascular reactivity changes to various catecholamines; reversal of
biochemical changes induced by diabetes and angiotensin II were also
observed [23]. Due to the antihypertensive effects and promotion of
cardiovascular health, pomegranate juice may be considered as a
dietary form of management for hypertension.
Citrus fruits, such as oranges and grapefruits, have also
demonstrated antihypertensive properties. A single-blind randomized
crossover study of 22 healthy patients aged 18-59 showed that after
drinking 500 ml/day of commercial citrus sinensis juice, both DBP and
SBP decreased (-5.13%, P=0.03 and -5.91%, P=0.0003, respectively),
while natural orange juice did not show significant effects [24]. Citrus
paradisi juice, from grapefruit, has many beneficial properties and is a
good source of vitamin C, pectin fiber, and antioxidants. Grapefruit
juice has been shown to decrease both SBP and DBP in both
normotensive and hypertensive human subjects [25]. Extract from
grapefruit peels is high in polyphenols, which act as strong inhibitors
of α-glucosidase and can be used in the management of hypertension
[26]. A study indicated that when compared, grapefruit juice produced
a greater decrease in mean arterial pressure than orange juice [25].
These studies indicate that fruits and vegetables can help manage blood
pressure through a wide variety of mechanisms, and should play a
major role in an antihypertensive dietary intervention.
Garlic is a vegetable that has been investigated for its cardiovascular
benefits. In addition to its antioxidant properties, the antihypertensive
effects of garlic have been linked to its allicin content, a sulfur
compound that can inhibit angiotensin II and promote vasodilation
[27]. A meta-analysis of 10 studies on garlic and hypertension
demonstrated a decrease in SBP of 8.4 ± 2.8 mmHg (p<0.001) and a
decrease in DBP of 7.3 ± 2.5 mmHg (p<0.001) among hypertensive
patients compared to placebo, though the form of garlic varied from
powder to oil to extract [27]. Another study by Ried, et al. evaluated
the effect that garlic extract supplementation had on the blood pressure
of 79 hypertension patients. The study showed a reduction in mean
SBP of 11.8 ± 5.4 mmHg (p=0.006) in patients taking two daily
capsules of garlic extract (1.2 mg S-allylcysteine) for 12 weeks
compared to placebo, a therapy regimen that was well-tolerated by the
cohort [28]. A meta-analysis by Wang et al. showed that garlic
supplementation in hypertensive patients resulted in a reduction in
SBP of -4.4 mmHg (95% CI: -7.37 to -1.42; p=0.004), and a reduction
in DBP of -2.68 mmHg (95% CI: -4.93 to -0.42; p=0.02) [29]. The
studies within the meta-analysis used garlic powder, garlic extract, and
garlic oil as garlic supplements [29]. Additionally, since it is primarily
used to enhance the flavor of food, it can reduce the desire to use salt
as a seasoning, presenting the patient with a palatable option for
reducing salt intake. In summary, garlic, due to multifactorial effects,
may be used to lower blood pressure.
Dairy products
Dairy products are major sources of protein and nutrition within
vegetarian diets and the Mediterranean Diet, both of which have been
shown to be effective in controlling blood pressure [16]. The
mechanisms by which dairy products help to manage blood pressure
are not entirely clear, but it is suspected that they correlate with the
magnesium and potassium contents of these food sources.
Additionally, bioactive peptides called lactotripeptides within dairy
products can contribute to the antihypertensive effects associated with
their consumption [16].
In a study by Drouin-Chartier et al., 76 weight-stable adults with
mild-to-moderate hypertension consumed three daily servings of dairy
products or a control that was equivalent in macronutrient and sodium
content during four-week treatment periods. The study demonstrated
an association between dairy consumption and a significant decrease
in ambulatory SBP in men (-2 mm Hg, p=0.05), though no significant
change in ambulatory DBP was observed (-1 mm Hg, p=0.37). The
observed effect on SBP was not significant in women. However,
endothelial function, as measured by the reactive hyperemia index
(RHI) significantly improved in both men and women consuming
dairy compared to controls when adjusted for energy intake (+0.09,
p=0.04) [16]. In the Rotterdam study, 2245 normotensive adults over
the age of 55 were assessed at baseline and after a 2-year follow-up and
6-year follow-up. This study demonstrated an inverse correlation
between low-fat dairy consumption and the incidence of hypertension
seen at 6-year follow-up: the hazard ratios (HR) and 95% confidence
interval (CI) across quartiles of increasing dairy consumption were
1.00; 0.89 (0.71 to 1.15); 0.84 (0.66 to 1.08); and 0.76 (0.59 to 0.97) in
overweight subjects (p=0.03 for trend) [30]. The greatest effect was
seen in consumption of low-fat milk and dairy products, and little risk
reduction was seen in consumption of high-fat dairy products and
cheese [30]. These results suggest that low-fat dairy products may be
useful in controlling hypertension, particularly among men and the
overweight, and should be considered within a dietary intervention.
Spices
Spices, including chili peppers, cinnamon, black pepper, and
turmeric, can also have antihypertensive effects. In addition to their
flavor-enhancing qualities, these spices have been used for centuries
worldwide as herbal medicines within the practice of traditional
medicine, and have become the subjects of increased focus within the
Western medical paradigm as possible adjunct therapies due to their
wide therapeutic indices and minimal side effect profiles.
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Capsaicin is the active component in red peppers, yellow peppers,
paprika peppers, and other plants in the Capsicum genus, and is a
natural irritant to humans. The effects of capsaicin on blood pressure
have been shown to vary depending on the amount ingested. Studies
have indicated that ingestion of large quantities of capsaicin-rich
peppers can induce a hypertensive crisis. The proposed explanation for
this reaction is via a decreased release of calcitonin gene-related
peptide (CGRP) from myocardial C fibers that are sensitive to
capsaicin [31,32]. While research has shown that ingestion of large
quantities of capsaicin can induce a hypertensive crisis, moderate
capsaicin consumption can have antihypertensive effects. Several
peppers from the Capsicum genus, including bell peppers and paprika,
exert a strong inhibitory effect on Angiotensin Converting Enzyme
(ACE). This research suggests that peppers of the Capsicum genus may
be useful as dietary cofactors in hypertension management, and
especially in ACE-dependent hypertension. A study performed by
Ranilla et al. demonstrated that the ACE inhibitory activity
significantly correlates with the total phenolic contents (r=0.61,
p<0.05) but not with the antioxidant activity, with paprika and red
peppers showing the highest ACE inhibition (92% and 84%
respectively) [33]. A similar study by Kwon et al. reported that yellow
pepper extracts had the highest ACE inhibitory activity (84.1%) while
red pepper extract ACE inhibitory activity was 76.5%, but found no
correlation between the total phenolic content and antioxidant activity
[34].
Cinnamon has been reported to reduce blood sugar in patients with
diabetes, and studies have shown that agents that enhance insulin
sensitivity or reduce circulating insulin levels also lower blood
pressure. Cinnamon extracts have been shown in several studies to
have antihypertensive and vasorelaxant effects in rats. In a study by
Nyadjeu et al. acute intravenous administration of the MECZ (5, 10,
and 20 mg/kg) showed long-lasting decrease in blood pressure (12.5%,
26.6%, and 30.6% respectively) in L-NAME-induced hypertensive rats
[35]. In another study by Nyadjeu et al. intravenous administration of
MECZ induced a significant (p<0.001) decrease in mean arterial blood
pressure in Wistar rates that has induced arterial hypertension from 20
mg/kg L-NAME injections [36]. The antihypertensive effects of
Cinnamon extracts may be a result of its ability to increase the
production of endogenous nitrous oxide (NO) or to regulate
dyslipidemia [36]. The addition of cinnamon to both high sucrose-
containing diets, which have known correlations to insulin resistance
and elevated blood pressure, and non-sucrose containing diets of rats
with spontaneous hypertension, has been shown to reduce SBP in a
dose-dependent manner. Preuss et al. found that the addition of 8%
weight/weight of cinnamon to the diets of rats eating sucrose lowered
the SBP to essentially that of the rate on starch only diets [37].
Black pepper is one of the most ubiquitous spices used in cuisine
worldwide. The essential oils within black pepper have known
antioxidant activity as well as the ability to inhibit ACE [38]. Black
pepper contains piperine, which is the chemical compound responsible
for its pungency. Piperine supplementation has been demonstrated to
normalize blood pressure and improve glucose tolerance, as well as
have positive cardiac and liver effects in rats on a high fat, high
carbohydrate diet that developed hypertension, elevated oxidative
stress and cardiac changes. Diwan et al. showed that piperine
normalized SBP after 8 weeks of treatment in rats fed a high
carbohydrate high fat diet (p <0.05) [39]. Piperine has also been shown
to partially prevent the increase in blood pressure in L-NAME-induced
hypertension, most likely via the blockade of voltage-dependent
calcium channels [40].
Curcumin, the active ingredient in turmeric, has many potential
beneficial effects on blood pressure. It has been shown to inhibit
hypertension-induced increase in myocardial cell diameter as well as
significant inhibition in perivascular fibrosis in rat models, and could
therefore be a therapeutic agent for heart failure, which can arise from
chronic uncontrolled hypertension [41]. Curcumin is also able to
partially prevent the increase in blood pressure caused by L-NAME,
NO-deficient hypertension, as well as prevent elastin decrease in the
aorta, which is important for maintaining vessel elasticity and
preventing arteriosclerosis [42]. In a study by Hlavackova et al.
administration of L-NAME increased the blood pressure in Wistar rats
to 157.4 mmHg, with further administration increasing this value
more; curcumin administration was able to stop the increase in blood
pressure caused by the L-NAME administration, while causing a
decrease of 28.9 mmHg throughout the experiment [42]. Nakmareong
et al. determined that the effect of curcumin on SBP during L-NAME
administration for 3 weeks, showing a significant decrease in SBP
(p<0.05) when compared with the L-NAME control group [43].
Curcumin’s ability to prevent development of vascular dysfunction in
NO-deficient hypertension is thought to be associated with its
antioxidant properties [43].
In summary, when formulating an antihypertensive diet, certain
spices can be helpful in the reduction and maintenance of blood
pressure. Like garlic, these spices enhance flavor for greater palatability,
and may help in lowering salt intake.
Green tea
Green tea is a commonly consumed beverage known for its
widespread health benefits. Of particular interest is a group of
polyphenols within green tea known as catechins, of which the key one
is epigallocatechin gallate (EGCG). EGCG stimulates nitric oxide
synthesis in endothelial cells to promote vasodilation and reduces
synthesis of endothelin-1, a vasoconstrictor, to improve overall
vascular function [44,45]. Additionally, EGCG might have an
inhibitory effect on the action of renin. By inhibiting this system at the
rate-limiting step of renin action, EGCG is able to effectively inhibit
fluid retention and vasoconstriction [46]. Additionally, by upregulating
HO-1, an enzyme also upregulated in response to stress and
inflammation, EGCG can exert a greater anti-inflammatory effect to
protect against endothelial damage and dysfunction [45].
In a longitudinal population study by Tong et al. conducted on 1109
Chinese adults, green tea consumption was demonstrated to inversely
correlate with changes in blood pressure over a five-year period in a
dose-dependent manner [47]. Among those who consumed the most
green tea (>10 g/day), DBP changes were minimized in nonsmoking
subjects (>10 g/day: -7.6 mmHg (95% CI: -11.96 to -3.24) versus <10
g/day: -3.43 mmHg (95%CI: -6.19 to -0.68), p<0.01 for trend), whereas
both SBP and DBP changes were minimized in nonobese nonsmoking
subjects [47]. However, subjects who smoked had a muted response to
green tea consumption [47]. Green tea consumption, or
supplementation with green tea flavonoids, could serve as an
alternative to sugar-sweetened beverages within the framework of a
diet to control hypertension.
Omega-3 fatty acids
Omega-3 fatty acids (n-3FAs) have been extensively studied for
their cardiovascular health benefits. The major types of omega-3 fatty
acids include eicosapentaenoic acid (EPA) and docosohexaenoic acid
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(DHA) found primarily in seafood and fish oil, and alpha-linolenic
acid (ALA) found primarily in plant sources such as flaxseed and
walnuts [48]. Omega-3 fatty acids are able to exert their
antihypertensive effects by regulating inflammatory signaling through
modulation of the expression of cytokines and prostaglandins with
vasoactive properties. N-3FAs accomplish this is by interaction with
the cyclooxygenase-1 (COX-1) enzyme to moderate prostaglandin
synthesis [49]. N-3FAs are also believed to regulate the levels of
oxylipins, which are vasoactive compounds produced by soluble
epoxide hydrolase derived from fatty acids. The oxylipins derived from
arachidonic acid or linoleic acid can have vasoconstrictive and
inflammatory effects, but n-3FAs can inhibit the activity of soluble
epoxide hydrolase, thereby reducing the production of such oxylipins
[50].
In the INTERMAP study, a population study of 4680 adults aged
40-59 from China, Japan, the United Kingdom, and the United States,
the dietary n-3FA intake was studied to determine its effect on blood
pressure. Participants were observed on two consecutive days at
baseline, then two consecutive days three weeks later. The results
showed an inverse correlation among all participants between dietary
n-3FA intake and both SBP and DBP after three weeks (>1.9 g/day
n-3FA: -0.55 mmHg SBP and -0.57 mmHg DBP), with ALA, DHA, and
EPA all demonstrating antihypertensive effects [51]. In a longitudinal
population study by Xun et al. of 4508 American adults aged 18-30
without hypertension at baseline, the incidence of hypertension was
monitored over a 20-year course. This study demonstrated that among
those in the highest quartile of n-3FA consumption (>0.37 g/day), the
incidence of hypertension was significantly lower at follow-up when
compared to those in the lowest quartile (HR=0.65 (95% CI:
0.53-0.79), p<0.01 for the trend) [52]. These studies suggest that
n-3FAs can result in modest SBP and DBP reduction when
supplemented or incorporated into an antihypertensive intervention
diet.
Trace elements
Several trace elements, such as copper and zinc, play an important
role in maintaining blood pressure. The exact method is not clear but
abnormal copper and zinc metabolism have been implicated as risk
factors for development of hypertension and vascular disease [53-55].
Serum calcium levels have been shown to be associated with
cardiovascular disease (CVD) [56], but the relation between calcium
and hypertension is not clear. Some studies, but not all, have shown
that increased intake of dietary calcium, and magnesium, reduces
blood pressure in patients with hypertension [57]. However, these
results have been seen only in dietary intake and not through
supplementation [58].
Magnesium affects blood pressure by modulating vascular tone
and reactivity. Hypomagnesemia is associated with diabetes and
metabolic syndrome, with magnesium playing a major role is
regulation of blood pressure [59]. Magnesium affects blood pressure by
modulating vascular tone and reactivity. As with calcium, the data is
not consistent, but there appears to be an inverse relationship with
dietary, not supplemental, magnesium intake and blood pressure [60].
While experimental data supports that low magnesium levels leads to
hypertension, clinical observation and trials have provided some
conflicting results [61]. While clinical trials have shown conflicting
results, there are studies that have demonstrated a significant
association between hypomagnesemia and prehypertension and
hypertension. In a study by Guerrero-Romero et al. of 3954 healthy
Mexican children, hypomagnesemia was observed in 59 children with
prehypertension (27.3%) and 52 (45.6%) with hypertension in the 6-10
age group and 115 children with prehypertension (36%) and 109
(49.6%) with hypertension in the 11-15 age group. Regression analysis
from the Guerrero-Romero study showed that hypomagnesemia was
associated with both prehypertension (6-10 years: p<0.0005; 11-15




Fructose is a sugar monomer that can exist in its free monomer
form, bound to glucose as a component of the sucrose dimer, and in
high levels in sweeteners such as high-fructose corn syrup (HFCS).
Common dietary sources of fructose include fruits and sugar-
sweetened beverages, as well as sources of sucrose, which is commonly
processed into table sugar from sugarcane. It has been a source of
dietary controversy, with excess consumption being linked to
metabolic disorders [63]. In the laboratory setting, fructose has been
demonstrated to induce hypertension and metabolic syndrome in rat
models [64]. One of the mechanisms by which fructose may be
implicated in hypertension is its contribution to elevated uric acid
levels. Metabolism of fructose is governed by an enzyme called
fructokinase, also known as ketohexokinase (KHK). Phosphorylation
of fructose is achieved by transferring a phosphate group from ATP,
but since KHK lacks a negative feedback mechanism, ATP is quickly
depleted, with the resulting dephosphorylated purines degraded by
AMP deaminase. This degradation results in increased uric acid levels
[63]. Hyperuricemia has been demonstrated in multiple studies to
correlate with hypertension [65-69], and so by this mechanism, it
would appear that excess fructose consumption would lead to
hypertension.
Demonstrating this link between fructose consumption and
hypertension within human populations, however, has been
controversial. Some studies have been able to demonstrate a link. In a
cross-sectional study by Jalal et al. of 4528 adults, 1754 of whom were
prehypertensive or had Stage 1 or Stage 2 hypertension, fructose
consumption was determined by dietary survey and its relation to
blood pressure was assessed. The median fructose consumption in this
study was 74 g/day, with consumption of at least 74 g/day
demonstrating an increased risk of elevated blood pressure (26%
increase for ≥ 135/85 mmHg, 30% increase for ≥ 140/90 mmHg, and
77% increase for ≥ 160/100 mmHg) [64]. In an INTERMAP study by
Brown et al. 2696 adults aged 40-59 from the United States and United
Kingdom, increased fructose consumption via sugar-sweetened
beverages was associated with a significantly increased risk of
hypertension in a dose dependent manner, with each 355 ml/day
increase in sugar-sweetened beverage intake corresponding to an
increase in SBP of +1.1 mmHg (p<0.001) and DBP of +0.4 mmHg
(p<0.05) when adjusted for subject weight and height. Furthermore,
fructose intake two standard deviations from the mean was associated
with an increase in SBP of +2.5 mmHg (p=0.002) and an increase in
DBP of 1.7 mmHg (p=0.002) when adjusted for subject weight and
height [70].
In contrast, other studies have not demonstrated a link between
fructose consumption and hypertension. In one study of 267 adults,
subjects were fed sugar-sweetened milk containing fructose, glucose,
sucrose, or HFCS, for 10 weeks. This study found no significant
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changes in blood pressure or uric acid levels between groups. However,
this study administered fructose in levels associated with the 50th
percentile population consumption level (49 ± 1.0 g/day as determined
in a study by Marriott, Cole, and Lee), and did not test the extremes of
fructose consumption that could be occurring within the standard
American diet [71,72]. Another study analyzed data from three major
longitudinal studies of over 200,000 people in total with each spanning
from 14-20 years: the Nurses’ Health Study 1 (NHS1), Nurses’ Health
Study 2 (NHS2), and the Health Professionals’ Follow-Up Study
(HPFS). Analysis of these studies did not demonstrate a significant link
between fructose consumption and the incidence of hypertension, with
an NHS1 relative risk of 1.02 (95% CI: 0.99-1.06); an NHS2 relative
risk of 1.03 (95% CI: 0.98-1.08); and an HPFS relative risk of 0.99 (95%
CI: 0.93-1.05) [73]. Though the link between fructose consumption
and hypertension may still be controversial, the mechanisms by which
fructose could possibly contribute to hypertension are plausible
enough that controlling the consumption of sugar-sweetened
beverages and added sugar within the framework of an
antihypertensive diet could be justified.
Sodium
Sodium has long been implicated in the development and
progression of hypertension. However, the mechanisms by which it
may contribute to hypertension are not fully clear. Sodium does play a
major role in fluid balance, and dysregulation in this process can
contribute to excess fluid retention, resulting in hypertension.
Additionally, sodium can also induce the production of
vasoconstrictive prostaglandins. This is a result of the action of sodium
on renal medullary interstitial cells, promoting NFҡB signaling and
COX-2 expression and leading to increased levels of PGE2 [74].
Dietary sodium restriction is one of the foundations of
antihypertensive diets. In a study of 412 adults that were
prehypertensive or mildly hypertensive, reductions in dietary sodium
were associated with decreases in SBP, with the greatest decreases
associated with the lowest sodium intakes. Compared to a high-
sodium control diet, a low-sodium (≤65 mmol/day) DASH diet was
associated with a decrease in SBP of 11.5 mmHg in patients with
hypertension, and a decrease in SBP of 7.1 mmHg in patients without
hypertension [75]. In a meta-analysis of 34 trials encompassing 3230
subjects, the mean reduction of 75 mmol/day of sodium (4.4 g/day)
resulted in a mean change in SBP of -4.18 mmHg (95% CI: -5.18 to
-3.18) and a mean decrease in DBP of 2.06 mmHg (95% CI: -2.67 to
-1.45). The relationship between decreased sodium intake and
decreased blood pressure was observed in both hypertensive and
normotensive subjects, and was demonstrated regardless of sex or
ethnicity [76]. These studies suggest that managing sodium intake is a
critical component in managing hypertension, and that an
antihypertensive diet should emphasize a reduction in dietary sodium
(Table 1).
Dietary Component Effect on Hypertension
Fruits and Vegetables:
Pomegranate Juice ↓





Chili Peppers (e.g. red peppers,





Omega-3 Fatty Acids ↓







Table 1: This table summarizes the dietary components reviewed in
this paper and their net effect on hypertension.*The effect of chili
peppers on hypertension varies based on the consumed amount.
Consumed in large quantities, chili peppers can promote hypertension,
but when consumed in moderate quantities, they have
antihypertensive effects.
Conclusion
The DASH diet is a safe and powerful tool in the management of
hypertension, and patient education by the physician and other health
professionals can play a major role in encouraging adherence to the
diet [14,15]. In counseling the patient, the physician must be educated
with regards to effective dietary strategies in order to present a specific
and coherent dietary plan, and present the patient with a wide array of
palatable options that can help encourage adherence to the
intervention. Education of the patient can thereby empower them with
the requisite health literacy to manage their blood pressure through
lifestyle modification. Particularly within medically underserved
populations, who are disproportionately affected by hypertension,
improved health literacy and patient self-sufficiency can have a major
impact on the management of this disease.
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